COVID-19 Vaccination Rates in a Global HIV Cohort

Academic Article

Abstract

  • Little is known regarding coronavirus disease 2019 (COVID-19) vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates among 6952 PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) compared to region- and country-specific vaccination data. The global probability of COVID-19 vaccination through end of July 2021 was 55% among REPRIEVE participants with rates varying substantially by Global Burden of Disease (GBD) superregion. Among PWH, factors associated with COVID-19 vaccination included residence in high-income regions, age, white race, male sex, body mass index, and higher cardiovascular risk.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Fulda ES; Fitch KV; Overton ET; Zanni MV; Aberg JA; Currier JS; Lu MT; Malvestutto C; Fichtenbaum CJ; Martinez E
  • Start Page

  • 603
  • End Page

  • 607
  • Volume

  • 225
  • Issue

  • 4